These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19807263)

  • 1. Economic burden of uncomplicated urinary tract infections: direct, indirect and intangible costs.
    Keating KN; Perfetto EM; Subedi P
    Expert Rev Pharmacoecon Outcomes Res; 2005 Aug; 5(4):457-66. PubMed ID: 19807263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic costs of overactive bladder in the United States.
    Ganz ML; Smalarz AM; Krupski TL; Anger JT; Hu JC; Wittrup-Jensen KU; Pashos CL
    Urology; 2010 Mar; 75(3):526-32, 532.e1-18. PubMed ID: 20035977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic considerations in overactive bladder.
    Hu TW; Wagner TH
    Am J Manag Care; 2000 Jul; 6(11 Suppl):S591-8. PubMed ID: 11183902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated cost of overactive bladder in Thailand.
    Prasopsanti K; Santi-Ngamkun A; Pornprasit K
    J Med Assoc Thai; 2007 Nov; 90(11):2316-20. PubMed ID: 18181313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Economic impact of healthcare-associated infections].
    Agozzino E; Di Palma MA; Gimigliano A; Piro A
    Ig Sanita Pubbl; 2008; 64(5):655-70. PubMed ID: 19188940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update: direct and indirect costs of arthritis and other rheumatic conditions--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 May; 53(18):388-9. PubMed ID: 15138399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database].
    Lim SJ; Kim HJ; Nam CM; Chang HS; Jang YH; Kim S; Kang HY
    J Prev Med Public Health; 2009 Jul; 42(4):251-60. PubMed ID: 19675402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].
    Bertrán MJ; Trilla A; Codina C; Carné X; Ribas J; Asenjo MA
    Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand.
    Osiri M; Maetzel A; Tugwell P
    J Rheumatol; 2007 Jan; 34(1):57-63. PubMed ID: 17183621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary study into the economic burden of cerebral palsy in China.
    Wang B; Chen Y; Zhang J; Li J; Guo Y; Hailey D
    Health Policy; 2008 Aug; 87(2):223-34. PubMed ID: 18282633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The total economic burden of overactive bladder in the United States: a disease-specific approach.
    Onukwugha E; Zuckerman IH; McNally D; Coyne KS; Vats V; Mullins CD
    Am J Manag Care; 2009 Mar; 15(4 Suppl):S90-7. PubMed ID: 19355803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden of illness imposed by severe sepsis in Austria.
    Schmid A; Schneider H; Adlof A; Smolle KH; Edelmann G; Sporn P; Frass M; Sumann G; Koller W; Schobersberger W
    Wien Klin Wochenschr; 2002 Aug; 114(15-16):697-701. PubMed ID: 12602114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic impact of overactive bladder syndrome in six Western countries.
    Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
    BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the cost of epilepsy in Europe: a review with economic modeling.
    Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
    Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost impact of COPD in Japan: opportunities and challenges?
    Nishimura S; Zaher C
    Respirology; 2004 Nov; 9(4):466-73. PubMed ID: 15612957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socioeconomic burden of schizophrenia: a targeted literature review of types of costs and associated drivers across 10 countries.
    Kotzeva A; Mittal D; Desai S; Judge D; Samanta K
    J Med Econ; 2023; 26(1):70-83. PubMed ID: 36503357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic costs of overactive bladder in Germany.
    Klotz T; Brüggenjürgen B; Burkart M; Resch A
    Eur Urol; 2007 Jun; 51(6):1654-62; discussion 1662-3. PubMed ID: 17161521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic impact of cardiovascular disease in Canada.
    Chan B; Coyte P; Heick C
    Can J Cardiol; 1996 Oct; 12(10):1000-6. PubMed ID: 9191493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.